← back to search

Priyathama Vellanki

Emory University · US
🔎 Find collaborators in Endocrinology, Diabetes and Metabolism · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Diabetes Management and Research, Hyperglycemia and glycemic control in critically ill and hospitalized patients, Diabetes Treatment and Management, and Diabetes and associated disorders.
h-index
28
citations
3,870
works
173
NIH funding
primary concept
Medicine
email

Recent publications

Results From a Randomized Trial of Intensive Glucose Management Using CGM Versus Usual Care in Hospitalized Adults With Type 2 Diabetes: The TIGHT Study
Diabetes Care 2024cited by 17position: middledoi
Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge
Endocrine Practice 2024cited by 9position: middledoi
Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test
The Journal of Clinical Endocrinology & Metabolism 2024cited by 3position: lastdoi
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
Endocrine Practice 2023cited by 349position: middledoi
Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes
Diabetes Care 2023cited by 28position: middledoi
The effects of aging and frailty on inpatient glycemic control by continuous glucose monitoring in patients with type 2 diabetes
Diabetes Research and Clinical Practice 2023cited by 10position: middledoi
American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update
Endocrine Practice 2022cited by 459position: middledoi
Continuous Glucose Monitoring–Guided Insulin Administration in Hospitalized Patients With Diabetes: A Randomized Clinical Trial
Diabetes Care 2022cited by 137position: middledoi
Accuracy of Dexcom G6 Continuous Glucose Monitoring in Non–Critically Ill Hospitalized Patients With Diabetes
Diabetes Care 2021cited by 150position: middledoi
Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial
Journal of Diabetes Science and Technology 2021cited by 36position: middledoi
Degludec hospital trial: A randomized controlled trial comparing insulin degludec <scp>U100</scp> and glargine <scp>U100</scp> for the inpatient management of patients with type 2 diabetes
Diabetes Obesity and Metabolism 2021cited by 25position: middledoi
Liraglutide hospital discharge trial: A randomized controlled trial comparing the safety and efficacy of liraglutide versus insulin glargine for the management of patients with type 2 diabetes after hospital discharge
Diabetes Obesity and Metabolism 2021cited by 24position: middledoi
Comparison of the FreeStyle Libre Pro Flash Continuous Glucose Monitoring (CGM) System and Point-of-Care Capillary Glucose Testing in Hospitalized Patients With Type 2 Diabetes Treated With Basal-Bolus Insulin Regimen
Diabetes Care 2020cited by 174position: middledoi
A Randomized Controlled Trial Comparing Glargine U300 and Glargine U100 for the Inpatient Management of Medicine and Surgery Patients With Type 2 Diabetes: Glargine U300 Hospital Trial
Diabetes Care 2020cited by 47position: middledoi
Clinical characteristics and outcomes of patients with end-stage renal disease hospitalized with diabetes ketoacidosis
BMJ Open Diabetes Research & Care 2020cited by 35position: middledoi
Preparedness cycle to address transitions in diabetes care during the COVID-19 pandemic and future outbreaks
BMJ Open Diabetes Research & Care 2020cited by 29position: middledoi
Safety And Efficacy Of Dpp-4 Inhibitors For The Management Of Hospitalized General Medicine And Surgery Patients with Type 2 Diabetes
Endocrine Practice 2020cited by 27position: middledoi
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction
Circulation 2019cited by 425position: middledoi
Clinical Outcomes in Patients With Isolated or Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State: A Retrospective, Hospital-Based Cohort Study
Diabetes Care 2019cited by 158position: middledoi
A Randomized Controlled Trial on the Safety and Efficacy of Exenatide Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Diabetes Care 2019cited by 83position: middledoi
Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis
Fertility and Sterility 2018cited by 103position: middledoi
Increasing Hospitalizations for DKA: A Need for Prevention Programs
Diabetes Care 2018cited by 81position: firstdoi
Glycaemic efficacy and safety of linagliptin compared to a basal‐bolus insulin regimen in patients with type 2 diabetes undergoing non‐cardiac surgery: A multicentre randomized clinical trial
Diabetes Obesity and Metabolism 2018cited by 79position: firstdoi
Clinical characteristics and outcomes of symptomatic and asymptomatic hypoglycemia in hospitalized patients with diabetes
BMJ Open Diabetes Research & Care 2018cited by 36position: middledoi
Treatment of Diabetic Ketoacidosis (DKA)/Hyperglycemic Hyperosmolar State (HHS): Novel Advances in the Management of Hyperglycemic Crises (UK Versus USA)
Current Diabetes Reports 2017cited by 160position: lastdoi
Stress hyperglycemia in general surgery: Why should we care?
Journal of Diabetes and its Complications 2017cited by 74position: middledoi
Diabetic Ketoacidosis: A Common Debut of Diabetes Among African Americans With Type 2 Diabetes
Endocrine Practice 2017cited by 72position: firstdoi
A Randomized Controlled Study Comparing a DPP4 Inhibitor (Linagliptin) and Basal Insulin (Glargine) in Patients With Type 2 Diabetes in Long-term Care and Skilled Nursing Facilities: Linagliptin-LTC Trial
Journal of the American Medical Directors Association 2017cited by 42position: middledoi
Report on Racial Disparities in Hospitalized Patients with Hyperglycemia and Diabetes
The Journal of Clinical Endocrinology & Metabolism 2016cited by 22position: middledoi
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCO-CABG Trial
Diabetes Care 2015cited by 279position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Guillermo E. Umpierrez · Emory University26 papers (2015–2024)Francisco J. Pasquel · Emory University20 papers (2015–2022)Maya Fayfman · Emory University15 papers (2015–2023)Saumeth Cardona · Emory University14 papers (2015–2022)Rodolfo J. Galindo · University of Miami14 papers (2018–2024)Limin Peng · Emory University13 papers (2015–2023)Georgia M. Davis · Emory University11 papers (2017–2022)Maria A. Urrutia · Emory University8 papers (2018–2021)Alexandra L. Migdal · Emory University7 papers (2019–2022)Bonnie Albury · Emory University7 papers (2019–2022)J. Sonya Haw · Emory University6 papers (2015–2020)Isabel Anzola · Emory University5 papers (2015–2021)Heqiong Wang · Apple (Israel)5 papers (2017–2020)Zohyra E. Zabala · Emory University3 papers (2023–2024)Clementina Ramos · Emory University3 papers (2018–2021)Dawn Smiley · Emory University3 papers (2015–2024)M. Citlalli Perez‐Guzman · University Health Network3 papers (2021–2022)Thaer Idrees · AID Atlanta3 papers (2022–2023)Anastasia‐Stefania Alexopoulos · Duke University2 papers (2015–2016)Katerina Tsegka · Emory University2 papers (2019–2020)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Endocrinology, Diabetes and Metabolism · Genetics →